INR 5007.55
(-0.83%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.33 Billion INR | -50.75% |
2022 | 8.47 Billion INR | -9.82% |
2021 | 9.4 Billion INR | 12.29% |
2020 | 8.37 Billion INR | -5.3% |
2019 | 8.84 Billion INR | 5.65% |
2018 | 8.36 Billion INR | 5.39% |
2017 | 7.94 Billion INR | -10.02% |
2016 | 8.82 Billion INR | -1.02% |
2015 | 8.91 Billion INR | 6.99% |
2014 | 8.33 Billion INR | 113.29% |
2013 | 3.9 Billion INR | -9.85% |
2012 | 4.33 Billion INR | -2.88% |
2011 | 4.46 Billion INR | 0.0% |
2010 | - INR | -100.0% |
2009 | 2.29 Billion INR | 14.91% |
2008 | 1.99 Billion INR | 520.74% |
2007 | 321.67 Million INR | -85.62% |
2006 | 2.23 Billion INR | -14.67% |
2005 | 2.62 Billion INR | 5.55% |
2004 | 2.48 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 933.1 Million INR | 0.6% |
2024 Q2 | 878.6 Million INR | -5.84% |
2023 Q4 | 927.5 Million INR | -58.3% |
2023 Q3 | 2.22 Billion INR | 9.42% |
2023 FY | 4.17 Billion INR | -50.75% |
2023 Q2 | 2.03 Billion INR | -7.73% |
2023 Q1 | 2.2 Billion INR | 9.51% |
2022 Q3 | 2.27 Billion INR | 9.64% |
2022 Q4 | 2.01 Billion INR | -11.55% |
2022 FY | 8.47 Billion INR | -9.82% |
2022 Q1 | 2.11 Billion INR | -6.32% |
2022 Q2 | 2.07 Billion INR | -2.01% |
2021 Q2 | 2.42 Billion INR | 12.4% |
2021 Q4 | 2.25 Billion INR | -11.57% |
2021 Q3 | 2.55 Billion INR | 5.29% |
2021 Q1 | 2.15 Billion INR | -9.9% |
2021 FY | 9.4 Billion INR | 12.29% |
2020 FY | 8.37 Billion INR | -5.3% |
2020 Q4 | 2.39 Billion INR | 13.37% |
2020 Q1 | 1.78 Billion INR | -20.72% |
2020 Q2 | 2.08 Billion INR | 16.76% |
2020 Q3 | 2.11 Billion INR | 1.62% |
2019 Q2 | 2.18 Billion INR | 3.03% |
2019 Q3 | 2.28 Billion INR | 4.6% |
2019 Q4 | 2.24 Billion INR | -1.72% |
2019 Q1 | 2.12 Billion INR | -1.57% |
2019 FY | 8.84 Billion INR | 5.65% |
2018 Q2 | 2.04 Billion INR | -5.2% |
2018 Q3 | 2 Billion INR | -2.13% |
2018 Q4 | 2.15 Billion INR | 7.52% |
2018 Q1 | 2.16 Billion INR | 24.58% |
2018 FY | 8.36 Billion INR | 5.39% |
2017 Q4 | 1.73 Billion INR | -10.13% |
2017 FY | 7.94 Billion INR | -10.02% |
2017 Q3 | 1.92 Billion INR | 6.92% |
2017 Q2 | 1.8 Billion INR | -16.72% |
2017 Q1 | 2.16 Billion INR | 9.29% |
2016 Q2 | 2.01 Billion INR | 5.17% |
2016 Q3 | 2.4 Billion INR | 19.84% |
2016 Q4 | 1.98 Billion INR | -17.69% |
2016 FY | 8.82 Billion INR | -1.02% |
2016 Q1 | 1.91 Billion INR | -10.09% |
2015 Q3 | 2.19 Billion INR | 5.12% |
2015 Q4 | 2.12 Billion INR | -3.24% |
2015 FY | 8.91 Billion INR | 6.99% |
2015 Q2 | 2.08 Billion INR | 9.53% |
2015 Q1 | 1.9 Billion INR | -20.16% |
2014 FY | 8.33 Billion INR | 113.29% |
2014 Q1 | 879.5 Million INR | -50.36% |
2014 Q2 | 1.06 Billion INR | 21.57% |
2014 Q3 | 2.25 Billion INR | 110.59% |
2014 Q4 | 2.38 Billion INR | 6.14% |
2013 Q2 | 586.7 Million INR | -24.3% |
2013 Q1 | 775 Million INR | -56.72% |
2013 FY | 3.9 Billion INR | -9.85% |
2013 Q4 | 1.77 Billion INR | 129.06% |
2013 Q3 | 773.5 Million INR | 31.84% |
2012 Q3 | 875.9 Million INR | 11.52% |
2012 FY | 4.33 Billion INR | -2.88% |
2012 Q4 | 1.79 Billion INR | 104.43% |
2012 Q1 | 941.8 Million INR | 0.0% |
2012 Q2 | 785.4 Million INR | -16.61% |
2011 Q3 | - INR | 0.0% |
2011 Q4 | - INR | 0.0% |
2011 FY | 4.46 Billion INR | 0.0% |
2010 FY | - INR | -100.0% |
2009 FY | 2.29 Billion INR | 14.91% |
2008 FY | 1.99 Billion INR | 520.74% |
2007 FY | 321.67 Million INR | -85.62% |
2006 FY | 2.23 Billion INR | -14.67% |
2005 FY | 2.62 Billion INR | 5.55% |
2004 FY | 2.48 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott India Limited | 5.98 Billion INR | 27.547% |
Cipla Limited | 59.21 Billion INR | 92.676% |
Gland Pharma Limited | 14.65 Billion INR | 70.407% |
GlaxoSmithKline Pharmaceuticals Limited | 4.35 Billion INR | 0.463% |
Kopran Limited | 1.41 Billion INR | -206.343% |
Marksans Pharma Limited | 3.28 Billion INR | -31.852% |
NGL Fine-Chem Limited | 1.75 Billion INR | -147.805% |
Sanofi India Limited | 4.13 Billion INR | -4.966% |
SMS Pharmaceuticals Limited | 769.2 Million INR | -463.854% |
TTK Healthcare Limited | 3.72 Billion INR | -16.549% |